Theranica Raises $6 Million to Combat Migraine
NETANYA, Israel, July 3, 2017 / PRNewswire
Theranica Bio-Electronics, a bio-medical technology company developing advanced electroceuticals for migraine and other prevalent diseases, announced the closing of its round A of financing, led by Lightspeed Venture Partners. Other investors participating in the round are LionBird venture capital firm and Corundum Open Innovation.
The funds, totaling about $6M will be used mainly to complete the regulatory process of the company's first product, for acute treatment of migraine, and to bring the product to mass production.